Loading clinical trials...
Loading clinical trials...
This is an open-label, single-treatment study. All subjects will receive 12 months of oral contraceptive therapy with DR-103. Study participants will receive physical and gynecological exams, includin...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Teva Women's Health
NCT05569070 · Teen Pregnancy Prevention
NCT06896539 · Unintended Pregnancy Prevention
NCT05950828 · HIV/AIDS Prevention, STI Prevention, and more
NCT03194672 · Pregnancy Prevention, Life Skill Development
NCT03366636 · Pregnancy Prevention, Sexual Behavior, and more
Teva Women's Health Research Investigational Site
Montgomery, Alabama
Teva Women's Health Research Investigational Site
Phoenix, Arizona
Teva Women's Health Research Investigational Site
Phoenix, Arizona
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions